Aflac stock (US0010551028): Largest U.S. insurance stock by market cap

Aflac holds the top spot among U.S. insurance stocks by market capitalization at $113.10 per share as of recent trading, underscoring its dominant position in the supplemental health and life insurance sector for American investors.

Aflac Incorporated, a leading provider of supplemental insurance, continues to lead U.S. insurance stocks by market capitalization. Shares traded at $113.10, down 0.2% recently, with a year-to-date gain of 7.1%, according to Simply Wall St as of May 2026. This positions Aflac ahead of peers like Allstate in market value, highlighting its stability amid sector volatility.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: AFLAC Inc.
• Sector/industry: Insurance
• Headquarters/country: United States
• Core markets: U.S., Japan
• Key revenue drivers: Supplemental health and life insurance
• Home exchange/listing venue: NYSE (AFL)
• Trading currency: USD

Aflac: core business model

Aflac specializes in supplemental insurance products, including cancer, accident, hospital, and life policies that complement primary health coverage. The company operates primarily in the U.S. and Japan, where it holds significant market share in voluntary benefits. This model allows employers to offer Aflac policies through payroll deductions, driving steady premium growth. Aflac's focus on innovative products like short-term disability coverage appeals to U.S. workers seeking financial protection beyond standard employer plans.

The business emphasizes direct-to-consumer marketing via its iconic duck mascot, enhancing brand recognition. In the U.S., Aflac targets small and mid-sized businesses, capturing a key segment of the $100+ billion supplemental insurance market. Its Japan operations contribute roughly half of revenues, providing geographic diversification relevant to U.S. investors tracking global exposure.

Main revenue and product drivers for Aflac

Premium income forms the bulk of Aflac's revenue, with U.S. supplemental health policies leading growth. Key products include accident insurance, which pays lump sums for injuries, and critical illness coverage addressing gaps in traditional plans. In fiscal 2025, U.S. sales rose due to expanded broker partnerships, per company reports. Japan's mature market delivers stable renewals, balancing U.S. expansion efforts.

Investment income from a conservative bond-heavy portfolio supports margins, with Aflac maintaining strong reserves for claims. Product innovation, such as telemedicine-integrated policies, positions it for rising healthcare costs in the U.S., a major concern for retail investors.

Industry trends and competitive position

The U.S. insurance sector faces rising demand for supplemental coverage amid high deductibles in employer-sponsored plans. Aflac benefits from this trend, holding over 30% share in voluntary benefits. Competitors like Colonial Life trail in brand awareness, giving Aflac an edge. Sector data from S&P Global highlights growing adoption post-pandemic, with supplemental premiums up 5-7% annually.

Why Aflac matters for US investors

Aflac's NYSE listing (AFL) and heavy U.S. revenue exposure make it a core holding for investors eyeing defensive sectors. Its dividends, consistently paid for decades, attract income-focused portfolios amid economic uncertainty. Exposure to Japan's stable insurance market adds resilience, relevant as U.S. investors diversify beyond domestic volatility.

Conclusion

Aflac maintains its lead as the largest U.S. insurance stock by market cap, with shares at $113.10 reflecting solid positioning in supplemental coverage. Ongoing U.S. growth and Japanese stability support its appeal, though sector headwinds like interest rates warrant monitoring. Investors track its role in diversified portfolios focused on income and resilience.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.